文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

重症COVID-19无需机械通气患者微循环功能障碍的检测与量化:三臂队列研究

DETECTION AND QUANTIFICATION OF MICROCIRCULATORY DYSFUNCTION IN SEVERE COVID-19 NOT REQUIRING MECHANICAL VENTILATION: A THREE-ARM COHORT STUDY.
PubMed 文献 · Shock · 2024-08-12
一句话结论重症COVID-19无需机械通气患者存在多参数微循环功能障碍证据,多模态可重复方法有助于急性微循环障碍检测。

这项前瞻性三臂队列研究纳入75例患者(每组25例),比较重症COVID-19急性呼吸衰竭无需机械通气患者与非COVID-19 ICU匹配对照的微血管功能,并设健康无合并症验证队列。主要终点为3分钟血管闭塞试验后反应性充血的组织氧再饱和斜率(rStO2),组间无显著差异。COVID-19患者达到灌注指数峰值时间更长(P=0.025),乙酰胆碱和硝普钠诱导的血管扩张减弱(P=0.010和P=0.018),微血管密度增加(P=0.019)。作者认为多模态方法有助于急性微循环障碍检测,但研究存在观察性设计、统计效能有限等局限。

要点

  • 重症COVID-19无需机械通气患者SOFA评分4.0[3.0;4.0] vs 非COVID ICU对照1.0[0;1.0],P<0.001,病情更重。
  • 主要终点rStO2在COVID-19与非COVID ICU对照间无显著差异。
  • COVID-19患者达到灌注指数峰值时间更长(P=0.025),提示微血管反应延迟。
  • 乙酰胆碱和硝普钠诱导的血管扩张减弱(P=0.010和P=0.018),微血管密度增加(P=0.019)。
  • 多模态微循环评估方法可重复,有助于急性微循环障碍检测,但统计效能有限。

适用人群与场景

  • COVID-19合并急性呼吸衰竭、无需机械通气的患者。
  • 非COVID-19 ICU匹配对照。
  • 健康、无合并症患者作为验证队列。

研究设计与关键结果

  • 前瞻性三臂队列研究,共纳入75例患者(每组25例)。
  • COVID-19组SOFA评分4.0[3.0;4.0] vs 非COVID ICU对照组1.0[0;1.0],P<0.001;PaO2/FiO2比值113[82;150] vs 443[348;533],P<0.001。
  • 主要终点rStO2在COVID-19组与非COVID ICU对照组间无显著差异。
  • COVID-19组达到灌注指数峰值时间更长(P=0.025)。
  • COVID-19组乙酰胆碱和硝普钠诱导的血管扩张减弱(P=0.010和P=0.018)。
  • COVID-19组微血管密度增加(P=0.019)。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:观察性设计、统计效能有限、单次微血管测量、组间疾病严重程度不同、治疗和疫苗接种可能影响微循环障碍。

对床旁实践的改变

  • 作者认为,本研究的可重复多模态方法有助于在多种临床应用中检测急性微循环障碍。

指南或共识出处

  • Clinical-Trials.gov(NCT04773899)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Aim: To identify and describe microcirculatory dysfunction (MD) in severe COVID-19 cases. Methods: This prospective, cohort study evaluated microvascular function in COVID-19 patients with acute respiratory failure not requiring mechanical ventilation and compared it with that of non-COVID-19 intensive care unit (ICU)-matched controls. A validation cohort included healthy, comorbidity-free patients. The primary outcome compared tissue oxygen resaturation slope (rStO 2 ) in COVID-19 patients and non-COVID ICU controls. rStO 2 was measured post a 3-min vaso-occlusive test during post-occlusive reactive hyperemia (PORH). Additionally, microvascular reactivity was assessed using perfusion index (PI) during PORH and laser speckle contrast imaging post iontophoresis with acetylcholine (ACH), sodium nitroprusside (SNP), and sublingual microcirculation. Results: Overall, 75 patients (25 per cohort) were included. COVID-19 patients exhibited greater severity than ICU controls, as indicated by their SOFA scores (4.0 [3.0; 4.0] vs. 1.0 [0; 1.0], P < 0.001) and PaO 2 /FiO 2 ratios (113 [82; 150] vs. 443 [348; 533], P < 0.001). No significant difference was observed in rStO 2 between the groups. COVID-19 patients showed longer time in reaching peak PI ( P = 0.025), reduced vasodilation with ACH and SNP ( P = 0.010 and P = 0.018, respectively), and increased microvascular density ( P = 0.019) compared to non-COVID-19 ICU controls. Conclusion: We observed evidence of MD in COVID-19 patients through various microcirculatory parameters. This study's reproducible multimodal approach facilitates acute MD detection across multiple clinical applications. Limitations included the observational design, limited statistical power, single-time microvascular measurements, varying illness severity among groups, and possible influences of treatments and vaccinations on MD. Trial registration : Clinical-Trials.gov (NCT04773899).

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Abrard S, Coquet T, Riou J, et al. DETECTION AND QUANTIFICATION OF MICROCIRCULATORY DYSFUNCTION IN SEVERE COVID-19 NOT REQUIRING MECHANICAL VENTILATION: A THREE-ARM COHORT STUDY. Shock. 2024. PMID: 39158987. doi:10.1097/SHK.0000000000002451

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。